PubMed Health⌕ Search

Biomedical subjects

Emi Uchibori

Publications and source records attributed to Emi Uchibori.

2 recordsLinked to original sources

A tetrazolium-based colorimetric assay for metabolic activity of stored blood platelets.

INTRODUCTION: Much work has been carried out in an attempt to establish the optimum cryopreservation of platelets. To estimate the surviving numbers of stored platelets, the metabolic redox activity of resting platelets was measured and compared with the aggregation response. MATERIALS AND METHODS: The activity was determined using a simple colorimetric assay based on reduction of a tetrazolium salt, WST-8 (4-[3-(2-methoxy-4-nitrophenyl)-2-[4-nitrophenyl]-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt), to water-soluble formazan and its quantification with a spectrophotometer. The aggregation response of the platelets was measured at 37 degrees C with an aggregometer. RESULTS: Colored WST-8 formazan was produced in proportion to the number of intact fresh platelets, but only a little or none was produced by dead platelets lysed by sodium dodecyl sulfate (SDS), by platelets in which glycolysis had been blocked by the inhibitor monoiodoacetic acid (MIA), and by frozen platelets. The assay in conjunction with platelet aggregometry could distinguish between platelets which had lost only the aggregation response and those which had lost both aggregation response and redox activity. Freezing platelets in the presence of cryoprotectant Banbanker resulted in approximately 70% fresh platelets with redox activity and aggregation response. CONCLUSIONS: These results indicate that the WST-8 assay can be useful for identifying viable platelets independent of the aggregation response and may contribute to clarifying the mechanism of the loss of function of stored platelets.

3T3 Cells↗

[Study on CH50 levels in factor D-depleted serum].

It is generally accepted that levels of serum whole complement activity (CH50) reflect the activities of complement (C) components of the classical C pathway (CP), since CH50 is assayed by use of sensitized sheep erythrocytes (EA). However, the alternative C pathway (AP) is considered to be also activated simultaneously in the process of activation of serum CP by EA. Thus, serum CH50 levels may possibly reflect not only CP but also AP activation in CH50 assay. We studied on the influence of AP activation during CH50 assay on CH50 levels, by comparison of CH50 levels in serum samples before and after treatment of factor D depletion. Polystyrene beads carrying polyanion, poly (2-acrylamide 2-methylpropane sulfonate) (PAMPS-beads), on the surface were prepared and used for preparation for factor D-depleted serum. After treatment of pooled normal human serum (NHS) with PAMPS-beads (2.5 mg/ml of serum), serum ACH50 level decreased to be undetectable, indicating that AP activation is prohibited in PAMPS-beads-treated serum. When isolated factor D was added to this PAMPS-beads-treated serum, ACH50 level recovered to that of before treatment. Immunoblot analysis revealed that factor D band observed in NHS disappeared completely after PAMPS-beads treatment. From these results, it is clear that factor-D deficient serum is prepared by PAMPS-beads treatment. Besides, since serum CH50 level was not decreased by PAMPS-beads treatment, it may be concluded that CH50 level is not affected by AP activation during CH50 assay.

Adult↗